5-methyl-2-(1-(2,3,4,6,6a,11,11a,11b-octahydro- 3-hydroxy-10,11b-dimethyl-1H-benzo(a)fluoren-9- yl)ethyl)piperidin-3-ol,
veratramin,
veratramine,
VERATRAMINE,
60-70-8,
NSC 17821,
NSC 23880,
UNII-RK363YG315,
HSDB 3545,
NSC17821,
NSC23880,
BRN 0055515,
CHEBI:9951,
(3beta,23beta)-14,15,16,17-Tetradehydroveratraman-3,23-diol,
RK363YG315,
Veratraman-3,23-diol, 14,15,16,17-tetradehydro-, (3-beta,23-beta)-,
(3beta,23R)-14,15,16,17-tetradehydroveratraman-3,23-diol,
Veratraman-3, 14,15,16,17-tetradehydro-, (3.beta.,23.beta.)-,
WLN: L D6 B566 LU&TTTJ A1 E1 OQ FY1&- BT6MTJ CQ E1,
NSC-23880,
AC1L1LQI,
5-21-05-00297 (Beilstein Handbook Reference),
SCHEMBL335680,
CHEMBL464724,
HY-N0837,
ZINC3875407,
BDBM50396007,
MFCD00468124,
NSC-17821,
AKOS030526858,
NSC17821;NSC23880,
CS-3005,
BCP0726000092,
LS-162032,
X0088,
C10829,
(3|A,23|A)-14,15,16,17-Teradehydroveratraman-3,23-diol,
Veratraman-3,23-diol, 14,15,16,17-tetradehydro-, (3beta,23beta)-,
Veratraman-3,23-diol, 14,15,16,17-tetradehydro-, (3beta,23beta)- (9CI),
(2S,3R,5S)-2-((S)-1-((3S,6aR,11aS,11bR)-3-hydroxy-10,11b-dimethyl-2,3,4,6,6a,11,11a,11b-octahydro-1H-benzo[a]fluoren-9-yl)ethyl)-5-methylpiperidin-3-ol,
(2S,3R,5S)-2-[(1S)-1-[(3S,6aR,11aS,11bR)-3-hydroxy-10,11b-dimethyl-1,2,3,4,6,6a,11,11a-octahydrobenzo[a]fluoren-9-yl]ethyl]-5-methyl-piperidin-3-ol,
(2S,3R,5S)-2-[(1S)-1-[(3S,6aR,11aS,11bR)-3-hydroxy-10,11b-dimethyl-1,2,3,4,6,6a,11,11a-octahydrobenzo[a]fluoren-9-yl]ethyl]-5-methylpiperidin-3-ol,
3-Piperidinol,5-methyl-2-[(1S)-1-[(3S,6aR,11aS,11bR)-2,3,4,6,6a,11,11a,11b-octahydro-3-hydroxy-10,11b-dimethyl-1H-benzo[a]fluoren-9-yl]ethyl]-,(2S,3R,5S)-,
C27H39NO2,
CID6070,
C27-H39-N-O2,
ACN-035849,
V0148,
14,15,16,17-Tetradehydroveratraman-3,23-diol,
(3-beta,23-beta)-14,15,16,17-Tetradehydroveratraman-3,23-diol,